Department of Oncology and Radiotherapy, Oulu University Hospital and University of Oulu, Oulu, Finland.
BMC Cancer. 2011 Jun 21;11:262. doi: 10.1186/1471-2407-11-262.
Triple-negative breast cancer (TNBC) and basal-like breast cancer (BLBC) are breast cancer subtypes with an especially poor prognosis. 8-Hydroxydeoxyguanosine (8-OHdG) is a widely used marker of oxidative stress and the redox-state-regulating enzymes peroxiredoxins (PRDXs) are efficient at depressing excessive reactive oxygen species. NF-E2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein 1 (Keap1) are redox-sensitive transcription factors that regulate PRDX expression. This is the first study to assess oxidative stress and or cell redox state-regulating enzymes in TNBC and BLBC.
We assessed immunohistochemical expression of 8-OHdG, Nrf2, Keap1, PRDX III and PRDX IV in 79 women with invasive ductal breast carcinomas. Of these tumors, 37 represented TNBC (grade II-III tumors with total lack of ER, PR and human epidermal growth factor receptor 2 [HER2] expression). Control cases (n = 42) were ER-positive, PR-positive and HER2-negative. Of the 37 TNBCs, 31 had BLBC phenotype (TNBC with expression of cytokeratin 5/6 or epidermal growth factor receptor 1).
Patients with TNBC had worse breast cancer-specific survival (BCSS) than the control group (p = 0.015). Expression of 8-OHdG was significantly lower in TNBC than in the non-TNBC group (p < 0.005). 8-OHdG immunostaining was associated with better BCSS (p = 0.01), small tumor size (p < 0.0001) and low grade (p < 0.0005). Keap1 overexpression was observed in the TNBC cohort (p = 0.001) and Keap1-positive patients had worse BCSS than Keap1-negative women (p = 0.014). PRDX IV was overexpressed in the TNBC vs. the non-TNBC group (p = 0.022).
Cellular redox state markers may be promising targets when elucidating the pathogenesis of TNBC.
三阴性乳腺癌(TNBC)和基底样乳腺癌(BLBC)是预后较差的乳腺癌亚型。8-羟基脱氧鸟苷(8-OHdG)是氧化应激的广泛使用标志物,而过氧化物还原酶(PRDXs)是有效抑制过多活性氧的还原态调节酶。NF-E2 相关因子 2(Nrf2)和 Kelch 样 ECH 相关蛋白 1(Keap1)是调节 PRDX 表达的氧化还原敏感转录因子。这是第一项评估 TNBC 和 BLBC 中氧化应激和/或细胞氧化还原状态调节酶的研究。
我们评估了 79 例浸润性导管乳腺癌女性的 8-OHdG、Nrf2、Keap1、PRDX III 和 PRDX IV 的免疫组织化学表达。这些肿瘤中,37 例为 TNBC(II-III 级肿瘤,总缺乏 ER、PR 和人表皮生长因子受体 2 [HER2]表达)。对照病例(n=42)为 ER 阳性、PR 阳性和 HER2 阴性。37 例 TNBC 中,31 例为 BLBC 表型(表达细胞角蛋白 5/6 或表皮生长因子受体 1 的 TNBC)。
TNBC 患者的乳腺癌特异性生存(BCSS)比对照组差(p=0.015)。与非 TNBC 组相比,TNBC 中 8-OHdG 的表达显著降低(p<0.005)。8-OHdG 免疫染色与更好的 BCSS 相关(p=0.01)、肿瘤体积小(p<0.0001)和低分级(p<0.0005)相关。在 TNBC 队列中观察到 Keap1 过表达(p=0.001),与 Keap1 阴性女性相比,Keap1 阳性患者的 BCSS 更差(p=0.014)。与非 TNBC 组相比,TNBC 中 PRDX IV 过表达(p=0.022)。
细胞氧化还原状态标志物在阐明 TNBC 的发病机制方面可能是有前途的靶点。